Vaccine Development

Scientists investigate novel approaches to vaccine development, focusing on the design and testing of immunogens that elicit protective immune responses. Research encompasses the creation of vaccines against infectious diseases, employing molecular biology techniques, immunology, and bioinformatics to identify and characterize target antigens. Studies explore various vaccine platforms, including subunit, inactivated, and live-attenuated vaccines, as well as newer modalities like mRNA and viral vector technologies. The work involves preclinical testing in relevant disease models to assess efficacy and safety.

This research holds significant relevance for Arkansas's agricultural economy, particularly its substantial livestock and poultry industries, by developing vaccines to protect animal health and reduce economic losses from disease outbreaks. Furthermore, advancements in vaccine technology contribute to public health preparedness and the control of zoonotic diseases that can impact human populations. Understanding immune responses in animal populations also informs strategies for sustainable agriculture and food security within the state.

The field draws upon expertise in microbial infections, host-pathogen interactions, and immune response mechanisms. Collaboration extends to areas such as animal nutrition and physiology, disease modeling, and potentially probiotics, fostering a comprehensive approach to infectious disease prevention and control.